A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis

Summary Background Nail psoriasis is common in patients with psoriasis and can seriously affect their quality of life. Current treatments are limited and there is no standard course of therapy. Objectives To assess the efficacy and safety of etanercept (ETN) on nail psoriasis in patients with mode...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of dermatology (1951) 2013-05, Vol.168 (5), p.1080-1087
Hauptverfasser:	Ortonne, J.P., Paul, C., Berardesca, E., Marino, V., Gallo, G., Brault, Y., Germain, J.M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Dermatology Dose-Response Relationship, Drug Drug Administration Schedule Etanercept Female Humans Immunoglobulin G - administration & dosage Immunoglobulin G - adverse effects Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - adverse effects Male Medical sciences Middle Aged Nail Diseases - drug therapy Nails Psoriasis - drug therapy Psoriasis. Parapsoriasis. Lichen Receptors, Tumor Necrosis Factor - administration & dosage Severity of Illness Index Time Factors Treatment Outcome Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!